Powered by: Motilal Oswal
2026-11-17 02:32:08 pm | Source: Prabhudas Lilladher Ltd
Buy Ahluwalia Contracts Ltd For Target Rs.708 by Prabhudas Liladhar Capital Ltd
Buy Ahluwalia Contracts Ltd For Target Rs.708 by Prabhudas Liladhar Capital Ltd

Margin improves QoQ

Ahluwalia reported a sharp sequential margin recovery in Q2FY27. Revenue grew 24.3% YoY, as large projects that started slowly in Q1 picked up. EBITDA margin recovering to 7.6% from 4.3% in Q1, though still well below 10.9% a year ago. Margin remained under pressure from a higher material share on early-stage EPC projects (Central Vista, CSMT), annual increments and higher PF outgo. Management retained 15%+ revenue growth for FY27 and guided 15–20% for FY28 but expects H2FY27 margins to stay around Q2 levels and FY28 margins at 8.5–9%. Order inflow guidance is now INR 40 bn, with ~INR 10 bn won so far. We cut FY28E/FY29E EPS by 16.1%/4.1% on lower margin assumptions and revise our TP to INR 708 at 15x 1HFY28 EPS (from INR 930). We retain BUY, as the stock trades at ~11x average FY28/29E EPS, below its 10-year average of ~19x, while a debt-free balance sheet and a net order book of INR 196.3 bn (~3.9x TTM revenue) support medium-term growth.

Strong execution; margin recovers but stays below last year:

Standalone revenue grew 24.3% YoY and 30.0% QoQ to INR 14,637 mn, taking H1FY27 growth to 18.7%. EBITDA fell 13.8% YoY to INR 1,109 mn, with margin at 7.6% (vs 10.9% YoY / 4.3% QoQ). Material cost rose to 47.0% of revenue from 40.5% a year ago. Management attributed this to project mix: on EPC jobs like Central Vista and CSMT, early billing only just covers material cost, and the material share should fall over the next 6–9 months. Employee cost rose 9.8% YoY to INR 1,326 mn on increments and the higher PF wage ceiling. PAT fell 29.4% YoY to INR 559 mn, also hit by a 56.2% YoY rise in depreciation to INR 348 mn.

Guidance - Revenue on track;margins capped:

Management retained FY27 revenue growth at 15%+ and guided 15–20% for FY28. Q3 revenue is expected at ~INR 13 bn (down ~10% QoQ) as GRAP shuts NCR sites for 1–1.5 months, with Q4 the strongest quarter. H2FY27 EBITDA margin is guided at around the Q2 level, and FY28 at 8.5–9% (at least 1pp higher). Management called double-digit margins hard to forecast, citing the PF change (~50bps margin impact), uncertain cost pass-through and supply-chain volatility. On escalation, about half of clients whose contracts lacked a labour escalation clause have agreed to pay it, and all new bids carry labour and material escalation clauses. Order inflow guidance is INR 40 bn against ~INR 10 bn won so far (YTD INR 5.6 bn plus the ~INR 3.5 bn Bennett University order in October), with INR 15 bn of bids submitted and a ~INR 50 bn pipeline.

Execution and balance sheet:

Central Vista is ramping up, with monthly billing of INR 430 mn in October, rising to ~INR 600 mn in November and INR 600–700 mn in December. That gives ~INR 1.5 bn in Q3 and over INR 2 bn in Q4, and management retained its FY27 target of ~INR 7 bn. CSMT has picked up after design approvals and is guided to ~INR 1.5 bn of billing in Q3 and ~INR 2 bn in Q4. India Jewellery Park is still awaiting the notice to proceed, and no revenue is expected in Q3. The balance sheet remains strong: it is debt-free, with ~INR 10 bn of cash, bank balances and liquid funds. Mobilisation advances stand at INR 9.39 bn (32% interest-bearing), retention at INR 4.37 bn and unbilled revenue at INR 9.25 bn. FY27 capex has been trimmed to ~INR 2.25 bn (H1: INR 1.42 bn), with FY28 at INR 2.2–2.5 bn.

 

Please refer disclaimer at Report
SEBI Registration number is INH000000933

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here